Payers using AI have fundamentally changed how claims get reviewed, and most labs are still operating as if nothing has changed.
The shift isn’t subtle. Payers have increasingly moved from manual claim review toward AI-driven adjudication at scale, and that transition has real consequences for how lab claims are evaluated, flagged, and denied.
Understanding what payers are doing with AI and why it matters for your revenue is no longer optional background knowledge. It’s a core part of running a sustainable lab revenue cycle.
Manual Review Is No Longer the Standard
Not long ago, payers would receive a claim, apply benefits per the coverage policy, and manually make a payment decision. That workflow is effectively gone. In 2026, payers are increasingly using AI-enabled systems to apply coverage policies and auto-adjudicate claims in real time. These systems don’t read claims the way a person would—they process data at high volume, compare patterns against benchmarks and policy rules, and make coverage decisions in seconds.
What makes this especially significant for labs is understanding exactly what a claim includes and what it doesn’t. A claim goes out with CPT codes, diagnosis codes, procedure information, and provider details. Supporting clinical documentation, such as the ordering rationale, clinical context, and patient history, is not part of the claim submission. It only comes into play if an appeal or an additional information request requires it.
That means payer AI is often making adjudication decisions based primarily on coded data, with little to no clinical context to inform them. For labs, this matters because if your coding patterns raise a flag for overuse of an unspecified code, unusual modifier frequency, or a volume spike, the system acts on that signal alone.
What Payer AI Is Looking For
AI medical claims auditing systems are trained to detect patterns that signal potential overutilization, miscoding, or documentation inconsistencies. Labs are encountering audit triggers in a few specific areas:
- Unlisted and unspecified codes. High-frequency use of codes like 87798 or non-specific ICD-10 diagnoses signals to payer systems that a lab may not be coding to the highest level of specificity. These codes are a known audit trigger, and volume matters.
- Modifier utilization. Modifiers like 59, 90, and 91 are legitimate — but payer AI compares modifier frequency against peer benchmarks. Outliers get flagged, regardless of whether the underlying billing is correct.
- Volume anomalies and new service lines. Sudden increases in claim volume or the addition of a new testing category can register as anomalies in a data pattern and draw closer review.
- Coding inconsistencies across claims. Patterns that a manual reviewer might never catch, spread across hundreds of claims, are exactly what machine learning is built to detect. Codes that don’t align with the typical clinical scenarios for a given provider type accumulate risk over time.
Past Payment Doesn’t Mean Past Review
One of the most significant changes in payer auditing behavior is the practice of retroactive audits. Receiving payment on a claim does not mean it was reviewed and approved in any final sense. Payers are increasingly returning months after initial payment to request documentation, challenge coding, and, in some cases, claw back reimbursement.
AI makes this operationally feasible at a scale that wasn’t previously possible. Payers can now run pattern analyses across large claim histories and surface discrepancies that trigger follow-up, long after the original payment was processed. A history of clean payments provides no protection against future scrutiny of those same claims.
No Lab Is Too Small to Be Targeted
The assumption that smaller labs, or labs focused on routine pathology or standard-of-care testing, are unlikely to be audit targets no longer reflects how payer AI operates. AI doesn’t require manual prioritization or human decisions about which provider to investigate.
Labs that have stayed under the radar for years because of their size or specialty mix are now just as visible to payer audit systems as large reference laboratories. Preparing for an audit is no longer something only high-volume or specialty-heavy labs need to think about. Every lab should be prepared for it.
What This Means for Your Revenue Cycle
What good lab billing looks like hasn’t changed. What has changed is how quickly gaps get flagged, and how little warning labs get before a denial or audit lands.
Labs in the strongest position are coding to the highest level of specificity, verifying eligibility against the correct downstream payer, maintaining documentation that substantiates every claim, and treating audit readiness as an ongoing operational standard rather than a reactive response. The labs that are absorbing the most damage are the ones still treating payer scrutiny as something that happens to other organizations.
SYNERGEN Health partners with labs across specialties to build revenue cycle management operations that withstand payer scrutiny—from front-end data quality and coding accuracy to back-end denial management and appeals automation.
Wondering where your revenue cycle stands? Request an RCM opportunity assessment.
